CPT® Code 81541

1. Indications

The CPT® Code 81541 is indicated for use in the assessment of prostate cancer progression risk. The following conditions and scenarios warrant the performance of this molecular genomic test:

• Prostate Cancer Diagnosis The test is utilized in patients who have been diagnosed with prostate cancer to evaluate the potential for disease progression.
• Risk Stratification It aids in stratifying patients based on their risk of disease progression, which is crucial for determining appropriate management strategies.
• Guiding Treatment Decisions The results can inform treatment planning, particularly in deciding between active surveillance and more aggressive treatment options such as surgery.

2. Procedure

The procedure for CPT® Code 81541 involves several critical steps to ensure accurate gene expression profiling. The following outlines the procedural steps:

• Step 1: Sample Collection A formalin-fixed paraffin-embedded tissue sample is obtained from the prostate tumor. This sample is essential for the subsequent analysis and must be handled according to standard protocols to preserve the integrity of the mRNA.
• Step 2: RNA Extraction The mRNA is extracted from the collected tissue sample. This step is crucial as it isolates the genetic material necessary for the real-time RT-PCR analysis.
• Step 3: Real-Time RT-PCR The extracted mRNA undergoes real-time reverse transcription polymerase chain reaction (RT-PCR). This technique amplifies the mRNA from the 46 targeted genes, allowing for quantification of gene expression levels.
• Step 4: Data Analysis The expression levels of the 31 content genes and 15 housekeeping genes are analyzed using a specific algorithm. This analysis generates a disease-specific mortality risk score based on the expression patterns observed.
• Step 5: Reporting Results The final step involves reporting the results, which include the calculated risk score ranging from -3 to +3. This score provides clinicians with valuable information regarding the likelihood of tumor progression and assists in making informed treatment decisions.

3. Post-Procedure

After the completion of the procedure associated with CPT® Code 81541, there are several considerations for post-procedure care. The results of the gene expression profiling will typically be reviewed in conjunction with other clinical findings and diagnostic tests. Clinicians will discuss the implications of the risk score with the patient, which may influence the management plan. Depending on the score, patients may be advised to consider options such as active surveillance, which involves regular monitoring of the cancer without immediate treatment, or more aggressive interventions like surgery. It is essential for patients to have follow-up appointments to reassess their condition and adjust treatment plans as necessary based on ongoing evaluations and any changes in their clinical status.